XGenomes
PrivateLast Round
Grant
Jul 15, 2024
Est. Valuation
$2.14M
Total Funding Raised
$22.79M
Company Overview
XGenomes is a biotechnology company developing a next-generation DNA sequencing platform that utilizes novel biochemistry, super-resolution single-molecule imaging, and artificial intelligence to provide rapid, accurate, and cost-effective genomic data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XGenomes Comparables
Compare XGenomes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxford Nanopore Technologies plc | 73% | |
| Illumina, Inc. | 71% | |
| Ultima Genomics | 70% | |
XGenomes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 15, 2024 | ||||
| Series A | Oct 26, 2021 | ||||
| Seed | Sep 4, 2019 | ||||
| Grant | Sep 3, 2019 | ||||
| Accelerator | Mar 18, 2019 | ||||
Grant | Jan 1, 2018 |
XGenomes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Better Ventures | Seed |
| RA Capital Management | Series A |
| The Engine | Series A |
| Engine Ventures | Seed |
| U.S. Department of Health and Human Services | Grant |
| B Capital Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 4, 2019
$3M round led by The Engine and Y Combinator.
- Sep 3, 2019
$200K grant from Massachusetts Life Sciences Center and NIH RADx.
XGenomes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about XGenomes's valuation, stock price, and market status.